Literature DB >> 17128699

Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection.

Panagiotis A Konstantinopoulos, Liron Pantanowitz, Bruce J Dezube.   

Abstract

The age-adjusted prevalence rate of monoclonal gammopathy of undetermined significance (MGUS) is three-fold higher in African Americans than whites. Similarly, there is a higher preponderance of multiple myeloma (MM) in African-American patients. Since the risk of progression of MGUS to MM is equal in both races, identification of exogenous and genetic risk factors of MGUS [such as genetic pre-disposition; diet; and chronic antigenic exposure related to sexually transmitted diseases, including human immunodeficiency virus (HIV) infection] is essential for unraveling the etiology of the racial disparity for MM. HIV infection, a well-documented risk factor for MGUS, is more frequent in African-American patients. Future epidemiologic studies dealing with plasma cell disorders should carefully examine the relationship between race, HIV infection status, prevalence of MGUS and its ultimate progression to MM.

Entities:  

Mesh:

Year:  2006        PMID: 17128699      PMCID: PMC2569800     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.

Authors:  Ola Landgren; Gloria Gridley; Ingemar Turesson; Neil E Caporaso; Lynn R Goldin; Dalsu Baris; Thomas R Fears; Robert N Hoover; Martha S Linet
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

Review 2.  Paraproteinemia, plasmacytoma, myeloma and HIV infection.

Authors:  A S Fiorino; B Atac
Journal:  Leukemia       Date:  1997-12       Impact factor: 11.528

3.  Hyperviscosity syndrome secondary to a myeloma-associated IgG(1)kappa paraprotein strongly reactive against the HIV-1 p24 gag antigen.

Authors:  D K Jin; M Nowakowski; M Kramer; D W Essex
Journal:  Am J Hematol       Date:  2000-07       Impact factor: 10.047

Review 4.  Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma.

Authors:  Bruce J Dezube; David M Aboulafia; Liron Pantanowitz
Journal:  AIDS Read       Date:  2004-07

5.  Spectrum of AIDS-associated malignant disorders.

Authors:  J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

Review 6.  Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus.

Authors:  Hetty Carraway; Richard F Ambinder
Journal:  Curr Opin Oncol       Date:  2002-09       Impact factor: 3.645

  6 in total
  6 in total

Review 1.  Monoclonal gammopathy of undetermined significance.

Authors:  Sébastien Anguille; Christian Bryant
Journal:  CMAJ       Date:  2013-05-21       Impact factor: 8.262

2.  Racial disparities in incidence and outcome in multiple myeloma: a population-based study.

Authors:  Adam J Waxman; Pamela J Mink; Susan S Devesa; William F Anderson; Brendan M Weiss; Sigurdur Y Kristinsson; Katherine A McGlynn; Ola Landgren
Journal:  Blood       Date:  2010-09-07       Impact factor: 22.113

3.  Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms.

Authors:  Woodrow J Coker; Ashley Jeter; Henning Schade; Yubin Kang
Journal:  Biomark Res       Date:  2013-02-04

4.  Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.

Authors:  Andrew J Cowan; Christine Allen; Aleksandra Barac; Huda Basaleem; Isabela Bensenor; Maria Paula Curado; Kyle Foreman; Rahul Gupta; James Harvey; H Dean Hosgood; Mihajlo Jakovljevic; Yousef Khader; Shai Linn; Deepesh Lad; Lorenzo Mantovani; Vuong Minh Nong; Ali Mokdad; Mohsen Naghavi; Maarten Postma; Gholamreza Roshandel; Katya Shackelford; Mekonnen Sisay; Cuong Tat Nguyen; Tung Thanh Tran; Bach Tran Xuan; Kingsley Nnanna Ukwaja; Stein Emil Vollset; Elisabete Weiderpass; Edward N Libby; Christina Fitzmaurice
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

5.  Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction.

Authors:  Manav Gandhi; Viral Bakhai; Jash Trivedi; Adarsh Mishra; Fernando De Andrés; Adrián LLerena; Rohit Sharma; Sujit Nair
Journal:  Transl Oncol       Date:  2022-09-11       Impact factor: 4.803

6.  Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis.

Authors:  Benjamin A Derman; Jagoda Jasielec; Spencer S Langerman; Wei Zhang; Andrzej J Jakubowiak; Brian C-H Chiu
Journal:  Blood Cancer J       Date:  2020-08-07       Impact factor: 11.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.